Andrew Hamer

2.5k total citations
41 papers, 1.2k citations indexed

About

Andrew Hamer is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Economics and Econometrics. According to data from OpenAlex, Andrew Hamer has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 20 papers in Cardiology and Cardiovascular Medicine and 6 papers in Economics and Econometrics. Recurrent topics in Andrew Hamer's work include Lipoproteins and Cardiovascular Health (15 papers), Acute Myocardial Infarction Research (8 papers) and Coronary Interventions and Diagnostics (7 papers). Andrew Hamer is often cited by papers focused on Lipoproteins and Cardiovascular Health (15 papers), Acute Myocardial Infarction Research (8 papers) and Coronary Interventions and Diagnostics (7 papers). Andrew Hamer collaborates with scholars based in United States, New Zealand and Australia. Andrew Hamer's co-authors include Frederick J. Raal, Andrea Ruzza, G. Kees Hovingh, Raúl D. Santos, Christopher E. Kurtz, Marc S. Sabatine, Dirk Blom, Robert P. Giugliano, Clare Williams and Eric D. Peterson and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Andrew Hamer

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Hamer United States	17	656	404	222	190	119	41	1.2k
Mette My Madsen Denmark	13	200 0.3×	356 0.9×	85 0.4×	228 1.2×	84 0.7×	30	1.3k
Ashish Sarraju United States	15	241 0.4×	194 0.5×	74 0.3×	150 0.8×	137 1.2×	57	932
F Lucy Wright United Kingdom	11	177 0.3×	464 1.1×	88 0.4×	109 0.6×	79 0.7×	15	1.3k
Alexandra N. Nowbar United Kingdom	14	525 0.8×	781 1.9×	67 0.3×	81 0.4×	332 2.8×	31	1.5k
Maren T. Scheuner United States	27	241 0.4×	371 0.9×	154 0.7×	261 1.4×	109 0.9×	71	2.6k
J. Gallagher Ireland	22	225 0.3×	806 2.0×	53 0.2×	127 0.7×	81 0.7×	102	1.7k
Anthony Matthews Sweden	16	129 0.2×	377 0.9×	102 0.5×	81 0.4×	106 0.9×	44	1.1k
Hwanhee Hong United States	24	168 0.3×	303 0.8×	131 0.6×	57 0.3×	167 1.4×	103	2.8k
Grigory Sidorenkov Netherlands	19	135 0.2×	179 0.4×	77 0.3×	130 0.7×	220 1.8×	79	1.0k
Michel H. Hof Netherlands	18	659 1.0×	175 0.4×	121 0.5×	249 1.3×	20 0.2×	43	1.4k

Countries citing papers authored by Andrew Hamer

Since Specialization

Citations

This map shows the geographic impact of Andrew Hamer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Hamer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Hamer more than expected).

Fields of papers citing papers by Andrew Hamer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Hamer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Hamer. The network helps show where Andrew Hamer may publish in the future.

Co-authorship network of co-authors of Andrew Hamer

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Hamer. A scholar is included among the top collaborators of Andrew Hamer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Hamer. Andrew Hamer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morrow, David A., Kazuma Oyama, Remo H.M. Furtado, et al.. (2022). Biomarker Prediction of Complex Coronary Revascularization Procedures in the FOURIER Trial. Journal of the American College of Cardiology. 80(9). 887–897. 4 indexed citations

Bansal, Sandeep, Andrea Ruzza, Vimal Mehta, et al.. (2021). Evolocumab in patients with homozygous familial hypercholesterolemia in India. Journal of clinical lipidology. 15(6). 814–821. 16 indexed citations

Schubert, Jessica, Bertil Lindahl, Håkan Melhus, et al.. (2020). Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study. European Heart Journal. 42(3). 243–252. 109 indexed citations

Santos, Raúl D., Andrea Ruzza, G. Kees Hovingh, et al.. (2020). Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia. New England Journal of Medicine. 383(14). 1317–1327. 115 indexed citations

Oyama, Kazuma, Remo H.M. Furtado, Thomas A. Zelniker, et al.. (2020). Effect of Evolocumab on Complex Coronary Disease Requiring Revascularization. Journal of the American College of Cardiology. 77(3). 259–267. 20 indexed citations

Santos, Raúl D., Evan A. Stein, G. Kees Hovingh, et al.. (2020). Long-Term Evolocumab in Patients With Familial Hypercholesterolemia. Journal of the American College of Cardiology. 75(6). 565–574. 118 indexed citations

Santos, Raúl D., G. Kees Hovingh, Dirk Blom, et al.. (2019). LONG-TERM EVOLOCUMAB USE IN SUBJECTS WITH HOMOZYGOUS AND SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: PRIMARY RESULTS OF THE TAUSSIG TRIAL. Journal of the American College of Cardiology. 73(9). 1715–1715. 3 indexed citations

Evans, Kaleigh L., Heidi S. Wirtz, Jia Li, et al.. (2019). Genetics of heart rate in heart failure patients (GenHRate). Human Genomics. 13(1). 22–22. 9 indexed citations

Koren, Michael J., Marc S. Sabatine, Robert P. Giugliano, et al.. (2019). Long-Term Efficacy and Safety of Evolocumab in Patients With Hypercholesterolemia. Journal of the American College of Cardiology. 74(17). 2132–2146. 108 indexed citations

10.

Sharma, Abhinav, Robert A. Harrington, Mark McClellan, et al.. (2018). Using Digital Health Technology to Better Generate Evidence and Deliver Evidence-Based Care. Journal of the American College of Cardiology. 71(23). 2680–2690. 208 indexed citations

11.

Elliott, John, Tom Kai Ming Wang, Greg Gamble, et al.. (2017). A decade of improvement in the management of New Zealand ST-elevation myocardial infarction (STEMI) patients: results from the New Zealand Acute Coronary Syndrome (ACS) Audit Group national audits of 2002, 2007 and 2012.. PubMed. 130(1453). 17–28. 3 indexed citations

12.

Makkar, Raj, Richard A. Schatz, Jay H. Traverse, et al.. (2014). TCT-152 ALLogeneic Heart STem Cells To Achieve Myocardial Regeneration (ALLSTAR): The Six Month Phase I Safety Results. Journal of the American College of Cardiology. 64(11). B46–B46. 4 indexed citations

13.

Tonkin, Andrew, David Hunt, Merryn Voysey, et al.. (2012). Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. American Heart Journal. 163(3). 508–514. 19 indexed citations

14.

Dowrick, Christopher, Josie Billington, Jude Robinson, Andrew Hamer, & Clare Williams. (2012). Get into Reading as an intervention for common mental health problems: exploring catalysts for change: Figure 1. Medical Humanities. 38(1). 15–20. 61 indexed citations

15.

Ellis, Chris, Greg Gamble, Andrew Hamer, et al.. (2010). Patients admitted with an acute coronary syndrome (ACS) in New Zealand in 2007: results of a second comprehensive nationwide audit and a comparison with the first audit from 2002.. PubMed. 123(1319). 25–43. 12 indexed citations

16.

Ellis, Chris, Gerard Devlin, John F. Elliott, et al.. (2010). ACS patients in New Zealand experience significant delays to access cardiac investigations and revascularisation treatment especially when admitted to non-interventional centres: results of the second comprehensive national audit of ACS patients.. PubMed. 123(1319). 44–60. 12 indexed citations

17.

Stewart, Ralph, Andrew Kerr, Gillian Whalley, et al.. (2010). Left ventricular systolic and diastolic function assessed by tissue Doppler imaging and outcome in asymptomatic aortic stenosis. European Heart Journal. 31(18). 2216–2222. 52 indexed citations

18.

Hartnell, George G., W B Crenshaw, Andrew J. Burger, & Andrew Hamer. (1996). Percutaneous Removal of a Fully Expanded Wallstent from the Right Ventricle with Transesophageal Echocardiography Guidance. Journal of Vascular and Interventional Radiology. 7(3). 371–374. 4 indexed citations

19.

White, Harvey D., D. Cross, Barbara F. Williams, et al.. (1995). “Rescue” thrombolysis with intracoronary tissue plasminogen activator for failed intravenous thrombolysis with streptokinase for acute myocardial infarction. The American Journal of Cardiology. 75(2). 172–174. 14 indexed citations

20.

Hamer, Andrew, et al.. (1993). Diagnosis of left atrial myxoma at routine coronary angiography in an asymptomatic patient. Catheterization and Cardiovascular Diagnosis. 30(3). 233–235. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact